The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Abstract
Chronic kidney disease (CKD) is a worldwide public health problem associated with a high prevalence of cardiovascular disease (CVD) and impaired quality of life. Previous research for preventing loss of glomerular filtration rate (GFR) has focused on reducing blood pressure (BP) and proteinuria. Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (ARB) are commonly used in patients with early CKD, but their value in advanced CKD (estimated GFR (eGFR) ≤30 ml/min/1.73 m 2) is unknown. There remains a debate about the omission of ACEi/ARB in patients with advanced CKD and their use in association with CVD or heart failure. Does the potential gain in eGFR with ACEi/ARB cessation outweigh the potential adverse cardiovascular outcomes? This paper reviews the current literature that addresses this issue. Several controversies are discussed. Although lowering BP reduces cardiovascular events, evidence suggests that ACEi/ARBs are not superior to other antihypertensive agents. There are no studies assessing the benefits of ACEi/ARB therapy in cardiovascular risk reduction in advanced non-dialysis CKD. The STOP ACEi trial will strengthen the evidence base and shed light on the potential merits and dangers of ACEi/ARB use in advanced CKD on renal function and cardiovascular outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Research works printed but not linked: 3
- 10.1159/000370275 · doi:10.1159/000370275
- 10.1093/ndt/gfq505 · doi:10.1093/ndt/gfq505
- 10.1159/000381477 · doi:10.1159/000381477
Cited by
Items 401–500 of 584
Frederix, I., Hansen, D., Coninx, K., Vandervoort, P., Vandijck, D., Hens, N., Van Craenenbroeck, E., Van Driessche, N., & Dendale, P. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4799 · Cited by 185
Bangalore, S., Fakheri, R., Toklu, B., & Messerli, F. H. (2016) · BMJ · doi:10.1136/bmj.i438 · Cited by 183
Bandak, G., Sang, Y., Gasparini, A., Chang, A. R., Ballew, S. H., Evans, M., Arnlov, J., Lund, L. H., Inker, L. A., Coresh, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005428 · Cited by 181
Rodríguez-Gutiérrez, R., & Montori, V. M. (2016) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.002901 · Cited by 176
Diabetes mellitus and stroke: A clinical update
Tun, N. N., Arunagirinathan, G., Munshi, S. K., & Pappachan, J. M. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.235 · Cited by 177
Oshima, M., Neuen, B. L., Li, J., Perkovic, V., Charytan, D. M., de Zeeuw, D., Edwards, R., Greene, T., Levin, A., Mahaffey, K. W., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050723 · Cited by 176
Hu, G., Jousilahti, P., Qiao, Q., Katoh, S., & Tuomilehto, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1730-6 · Cited by 176
Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study
Rebholz, C. M., Coresh, J., Grams, M. E., Steffen, L. M., Anderson, C. A. M., Appel, L. J., & Crews, D. C. (2015) · American Journal of Nephrology · doi:10.1159/000443746 · Cited by 173
Chiavaroli, L., Mirrahimi, A., Sievenpiper, J. L., Jenkins, D. J. A., & Darling, P. B. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.237 · Cited by 170
Gilstrap, L. G., Fonarow, G. C., Desai, A. S., Liang, L., Matsouaka, R., DeVore, A. D., Smith, E. E., Heidenreich, P., Hernandez, A. F., Yancy, C. W., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004675 · Cited by 169
Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms
Kaur, J., Young, B., & Fadel, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081682 · Cited by 168
Cardiovascular disease after cancer therapy
Aleman, B. M. P., Moser, E. C., Nuver, J., Suter, T. M., Maraldo, M. V., Specht, L., Vrieling, C., & Darby, S. C. (2014) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2014.03.002 · Cited by 168
Failure of ICD‐9‐CM Codes to Identify Patients with Comorbid Chronic Kidney Disease in Diabetes
Kern, E. F. O., Maney, M., Miller, D. R., Tseng, C., Tiwari, A., Rajan, M., Aron, D., & Pogach, L. (2006) · Health Services Research · doi:10.1111/j.1475-6773.2005.00482.x · Cited by 165
Muscle‐bone crosstalk and potential therapies for sarco‐osteoporosis
Li, G., Zhang, L., Wang, D., AIQudsy, L., Jiang, J. X., Xu, H., & Shang, P. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28946 · Cited by 166
The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney Disease
Stadler, K., Goldberg, I. J., & Susztak, K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0611-8 · Cited by 165
Cardiovascular organ-on-a-chip platforms for drug discovery and development
Ribas, J., Sadeghi, H., Manbachi, A., Leijten, J., Brinegar, K., Zhang, Y. S., Ferreira, L., & Khademhosseini, A. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0002 · Cited by 161
F. Piepoli, M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9583-6 · Cited by 162
Egan, B. M., Zhao, Y., Li, J., Brzezinski, W. A., Todoran, T. M., Brook, R. D., & Calhoun, D. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01448 · Cited by 158
Sanches Machado d’Almeida, K., Ronchi Spillere, S., Zuchinali, P., & Corrêa Souza, G. (2018) · Nutrients · doi:10.3390/nu10010058 · Cited by 157
Schmidt, M., Mansfield, K. E., Bhaskaran, K., Nitsch, D., Sørensen, H. T., Smeeth, L., & Tomlinson, L. A. (2017) · BMJ · doi:10.1136/bmj.j791 · Cited by 157
Chung, E. Y., Ruospo, M., Natale, P., Bolignano, D., Navaneethan, S. D., Palmer, S. C., & Strippoli, G. F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007004.pub4 · Cited by 157
Gene therapy for the treatment of heart failure: promise postponed
Hulot, J.-S., Ishikawa, K., & Hajjar, R. J. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw019 · Cited by 150
Jackson, A. M., Jhund, P. S., Anand, I. S., Düngen, H.-D., Lam, C. S. P., Lefkowitz, M. P., Linssen, G., Lund, L. H., Maggioni, A. P., Pfeffer, M. A., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab499 · Cited by 156
Bello, A. K., Hemmelgarn, B., Lloyd, A., James, M. T., Manns, B. J., Klarenbach, S., & Tonelli, M. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09741110 · Cited by 151
Shin, J.-I., Chang, A. R., Grams, M. E., Coresh, J., Ballew, S. H., Surapaneni, A., Matsushita, K., Bilo, H. J. G., Carrero, J. J., Chodick, G., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17323 · Cited by 155
Mathew, J. S., Sachs, M. C., Katz, R., Patton, K. K., Heckbert, S. R., Hoofnagle, A. N., Alonso, A., Chonchol, M., Deo, R., Ix, J. H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005499 · Cited by 153
Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis
Oliver-Williams, C. T., Heydon, E. E., Smith, G. C. S., & Wood, A. M. (2013) · Heart · doi:10.1136/heartjnl-2012-303237 · Cited by 151
Bakris, G. L., Sica, D., Weber, M., White, W. B., Roberts, A., Perez, A., Cao, C., & Kupfer, S. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00425.x · Cited by 143
Herrington, W. G., Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D. R., Coresh, J., & Woodward, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173515 · Cited by 141
Patient selection in heart failure with preserved ejection fraction clinical trials
Kelly, J. P., Mentz, R. J., Mebazaa, A., Voors, A. A., Butler, J., Roessig, L., Fiuzat, M., Zannad, F., Pitt, B., O’Connor, C. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.043 · Cited by 139
Awada, H. K., Johnson, N. R., & Wang, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.034 · Cited by 138
The Vasculature in Prediabetes
Wasserman, D. H., Wang, T. J., & Brown, N. J. (2018) · Circulation Research · doi:10.1161/circresaha.118.311912 · Cited by 137
Averitt, A. J., Weng, C., Ryan, P., & Perotte, A. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0277-8 · Cited by 137
Management of Iron Deficiency Anemia.
(2015) · PubMed Central · Cited by 136
Singh, A., Nadkarni, G., Gottesman, O., Ellis, S. B., Bottinger, E. P., & Guttag, J. V. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.005 · Cited by 136
Excess Weight and the Risk of Incident Coronary Heart Disease Among Men and Women
Flint, A. J., Hu, F. B., Glynn, R. J., Caspard, H., Manson, J. E., Willett, W. C., & Rimm, E. B. (2010) · Obesity · doi:10.1038/oby.2009.223 · Cited by 134
Sex and gender differences in myocarditis and dilated cardiomyopathy: An update
Fairweather, D., Beetler, D. J., Musigk, N., Heidecker, B., Lyle, M. A., Cooper, L. T., & Bruno, K. A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1129348 · Cited by 124
Perotte, A., Ranganath, R., Hirsch, J. S., Blei, D., & Elhadad, N. (2015) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocv024 · Cited by 128
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
Rienstra, M., Tzeis, S., Bunting, K. V., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Sanders, P., Svennberg, E., Casado-Arroyo, R., Dwight, J., et al. (2024) · Europace · doi:10.1093/europace/euae298 · Cited by 128
Low protein diets for non-diabetic adults with chronic kidney disease
Hahn, D., Hodson, E. M., & Fouque, D. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001892.pub4 · Cited by 128
Combination therapy for kidney disease in people with diabetes mellitus
van Raalte, D. H., Bjornstad, P., Cherney, D. Z. I., de Boer, I. H., Fioretto, P., Gordin, D., Persson, F., Rosas, S. E., Rossing, P., Schaub, J. A., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00827-z · Cited by 127
Whole grains and incident hypertension in men.
Flint, A. J., Hu, F. B., Glynn, R. J., Jensen, M. K., Franz, M., Sampson, L., & Rimm, E. B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27460 · Cited by 126
A critical review of mathematical models and data used in diabetology
Boutayeb, A., & Chetouani, A. (2006) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-5-43 · Cited by 126
Tonneijck, L., Smits, M. M., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., & van Raalte, D. H. (2016) · Diabetologia · doi:10.1007/s00125-016-3938-z · Cited by 126
Chaudhuri, A., Ghanim, H., & Arora, P. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14601 · Cited by 120
Michos, E. D., Bakris, G. L., Rodbard, H. W., & Tuttle, K. R. (2023) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2023.100502 · Cited by 125
Diabetes, hypertension, and cardiovascular derangements: Pathophysiology and management
El-Atat, F., McFarlane, S. I., & Sowers, J. R. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0072-y · Cited by 121
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Agarwal, R., Anker, S. D., Bakris, G., Filippatos, G., Pitt, B., Rossing, P., Ruilope, L., Gebel, M., Kolkhof, P., Nowack, C., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa294 · Cited by 103
Targeting the sarcomere to correct muscle function
Hwang, P. M., & Sykes, B. D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4554 · Cited by 114
The role of epigenetics in renal ageing
Shiels, P. G., McGuinness, D., Eriksson, M., Kooman, J. P., & Stenvinkel, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.78 · Cited by 114
Wright, J. T. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.66 · Cited by 114
Phosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function
Rosas, P. C., Liu, Y., Abdalla, M. I., Thomas, C. M., Kidwell, D. T., Dusio, G. F., Mukhopadhyay, D., Kumar, R., Baker, K. M., Mitchell, B. M., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001550 · Cited by 112
Catalá-López, F., Macías Saint-Gerons, D., González-Bermejo, D., Rosano, G. M., Davis, B. R., Ridao, M., Zaragoza, A., Montero-Corominas, D., Tobías, A., de la Fuente-Honrubia, C., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001971 · Cited by 109
Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial
The EMPA-KIDNEY Collaborative Group, Herrington, W. G., Wanner, C., Green, J. B., Hauske, S. J., Judge, P., Mayne, K. J., Ng, S. Y. A., Sammons, E., Zhu, D., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac040 · Cited by 110
Zheng, Y., Lin, J., Liu, D., Wan, G., Gu, X., & Ma, J. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04754-4 · Cited by 110
Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events
Zhan, S., Tang, M., Liu, F., Xia, P., Shu, M., & Wu, X. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012502.pub2 · Cited by 109
SGLT2-inhibitors; more than just glycosuria and diuresis
Fathi, A., Vickneson, K., & Singh, J. S. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10038-w · Cited by 109
Doxorubicin‐Induced Cardiomyopathy in Children
Mancilla, T. R., Iskra, B., & Aune, G. J. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180017 · Cited by 108
Engineered 3D cardiac fibrotic tissue to study fibrotic remodeling
Sadeghi, A. H., Shin, S. R., Deddens, J. C., Fratta, G., Mandla, S., Yazdi, I. K., Prakash, G., Antona, S., Demarchi, D., Buijsrogge, M. P., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201601434 · Cited by 108
Murphy, D. P., Drawz, P. E., & Foley, R. N. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018100971 · Cited by 106
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention
Michaeli, D. T., Michaeli, J. C., Albers, S., Boch, T., & Michaeli, T. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00594-5 · Cited by 109
Lundgren, J. G., Dahlström, Ö., Andersson, G., Jaarsma, T., Kärner Köhler, A., & Johansson, P. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.5556 · Cited by 104
Cichosz, S. L., Johansen, M. D., & Hejlesen, O. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815611680 · Cited by 101
Medrano-Gracia, P., Cowan, B. R., Ambale-Venkatesh, B., Bluemke, D. A., Eng, J., Finn, J. P., Fonseca, C. G., Lima, J. A., Suinesiaputra, A., & Young, A. A. (2014) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-014-0056-2 · Cited by 98
Timeline of History of Hypertension Treatment
Saklayen, M. G., & Deshpande, N. V. (2016) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2016.00003 · Cited by 96
Dussold, C., Gerber, C., White, S., Wang, X., Qi, L., Francis, C., Capella, M., Courbon, G., Wang, J., Li, C., et al. (2019) · Bone Research · doi:10.1038/s41413-019-0051-1 · Cited by 96
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
Zhu, Y., Prata, L. G. P. L., Gerdes, E. O. W., Netto, J. M. E., Pirtskhalava, T., Giorgadze, N., Tripathi, U., Inman, C. L., Johnson, K. O., Xue, A., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103912 · Cited by 100
Liu, L., Yu, H., Zhao, H., Wu, Z., Long, Y., Zhang, J., Yan, X., You, Z., Zhou, L., Xia, T., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1910650117 · Cited by 94
Bakris, G. L., Weir, M. R., & on behalf of the Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators (2003) · The Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2002.2041.x · Cited by 94
The renin–angiotensin–aldosterone system and calcium-regulatory hormones
Vaidya, A., Brown, J. M., & Williams, J. S. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2014.125 · Cited by 93
Statistical Shape Modeling of the Left Ventricle: Myocardial Infarct Classification Challenge
Suinesiaputra, A., Dhooge, J., Duchateau, N., Ehrhardt, J., Frangi, A. F., Gooya, A., Grau, V., Lekadir, K., Lu, A., Mukhopadhyay, A., et al. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2017.2652449 · Cited by 95
Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression
Du Bois, P., Pablo Tortola, C., Lodka, D., Kny, M., Schmidt, F., Song, K., Schmidt, S., Bassel-Duby, R., Olson, E. N., & Fielitz, J. (2015) · Circulation Research · doi:10.1161/circresaha.114.305393 · Cited by 92
George, C., Echouffo-Tcheugui, J. B., Jaar, B. G., Okpechi, I. G., & Kengne, A. P. (2022) · BMC Medicine · doi:10.1186/s12916-022-02438-6 · Cited by 91
Pharmacology and Clinical Drug Candidates in Redox Medicine
Dao, V. T.-V., Casas, A. I., Maghzal, G. J., Seredenina, T., Kaludercic, N., Robledinos-Anton, N., Di Lisa, F., Stocker, R., Ghezzi, P., Jaquet, V., et al. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6430 · Cited by 88
Oellgaard, J., Gæde, P., Rossing, P., Rørth, R., Køber, L., Parving, H.-H., & Pedersen, O. (2018) · Diabetologia · doi:10.1007/s00125-018-4642-y · Cited by 86
PoLA/CFPiP/PCS guidelines for the management of dyslipidaemias for family physicians 2016
Banach, M., Jankowski, P., Jóźwiak, J., Cybulska, B., Windak, A., Guzik, T., Mamcarz, A., Broncel, M., & Tomasik, T. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.64712 · Cited by 86
Kuznik, A., Mardekian, J., & Tarasenko, L. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-132 · Cited by 86
Current Concepts in the Treatment of Renovascular Hypertension
Herrmann, S. M., & Textor, S. C. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpx154 · Cited by 84
Chen, J.-J., Wu, C.-Y., Jenq, C.-C., Lee, T.-H., Tsai, C.-Y., Tu, H.-T., Huang, Y.-T., Yen, C.-L., Yen, T.-H., Chen, Y.-C., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.1169 · Cited by 82
Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism
Gutiérrez, O. M., Luzuriaga-McPherson, A., Lin, Y., Gilbert, L. C., Ha, S.-W., & Beck, G. R. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2279 · Cited by 82
Williams, J. B., DeLong, E. R., Peterson, E. D., Dokholyan, R. S., Ou, F.-S., & Ferguson, T. B. (2011) · Circulation · doi:10.1161/circulationaha.110.981068 · Cited by 79
Grubbs, V., Lin, F., Vittinghoff, E., Shlipak, M. G., Peralta, C. A., Bansal, N., Jacobs, D. R., Siscovick, D. S., Lewis, C. E., & Bibbins-Domingo, K. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.055 · Cited by 79
Yokote, K., Yamashita, S., Arai, H., Araki, E., Suganami, H., & Ishibashi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030706 · Cited by 79
Nelson, A. J., O’Brien, E. C., Kaltenbach, L. A., Green, J. B., Lopes, R. D., Morse, C. G., Al-Khalidi, H. R., Aroda, V. R., Cavender, M. A., Gaynor, T., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.48030 · Cited by 78
HCN Channels Modulators: The Need for Selectivity
Novella Romanelli, M., Sartiani, L., Masi, A., Mannaioni, G., Manetti, D., Mugelli, A., & Cerbai, E. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616999160315130832 · Cited by 73
Underutilisation of ACE inhibitors in patients with congestive heart failure.
Bungard, T. J., McAlister, F. A., Johnson, J. A., & Tsuyuki, R. T. (2001) · Drugs · doi:10.2165/00003495-200161140-00002 · Cited by 73
The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF
Withaar, C., Meems, L. M. G., Nollet, E. E., Schouten, E. M., Schroeder, M. A., Knudsen, L. B., Niss, K., Madsen, C. T., Hoegl, A., Mazzoni, G., et al. (2023) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2023.05.012 · Cited by 74
Yang, M., Song, L., Wang, L., Yukht, A., Ruther, H., Li, F., Qin, M., Ghiasi, H., Sharifi, B. G., & Shah, P. K. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.061 · Cited by 73
Brown, J., de Boer, I. H., Robinson-Cohen, C., Siscovick, D. S., Kestenbaum, B., Allison, M., & Vaidya, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3949 · Cited by 71
Shi, F., Sun, L., & Kaptoge, S. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.01.018 · Cited by 70
Resistant hypertension: an approach to management in primary care
Yaxley, J., & Thambar, S. (2015) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.154630 · Cited by 70
Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L. M., Mollenhauer, B., Foroud, T., Galasko, D., et al. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-223433 · Cited by 70
Murphy, T. P., Cooper, C. J., Pencina, K. M., D’Agostino, R., Massaro, J., Cutlip, D. E., Jamerson, K., Matsumoto, A. H., Henrich, W., Shapiro, J. I., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07744 · Cited by 69
Le, R., Nguyen, M. T., Allahwala, M. A., Psaltis, J. P., Marathe, C. S., Marathe, J. A., & Psaltis, P. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164674 · Cited by 66
Mann, B. S., Barnieh, L., Tang, K., Campbell, D. J. T., Clement, F., Hemmelgarn, B., Tonelli, M., Lorenzetti, D., & Manns, B. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089168 · Cited by 66
Bramlage, P., Lanzinger, S., van Mark, G., Hess, E., Fahrner, S., Heyer, C. H. J., Friebe, M., Seufert, J., Danne, T., & Holl, R. W. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0837-x · Cited by 65
Fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults
Panwar, B., Jenny, N. S., Howard, V. J., Wadley, V. G., Muntner, P., Kissela, B. M., Judd, S. E., & Gutiérrez, O. M. (2015) · Stroke · doi:10.1161/strokeaha.114.007489 · Cited by 65
Jefferis, B. J., Parsons, T. J., Sartini, C., Ash, S., Lennon, L. T., Papacosta, O., Morris, R. W., Wannamethee, S. G., Lee, I.-M., & Whincup, P. H. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.12.024 · Cited by 65
Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
Scheele, W., Diamond, S., Gale, J., Clerin, V., Tamimi, N., Le, V., Walley, R., Grover-Páez, F., Perros-Huguet, C., Rolph, T., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050473 · Cited by 65
Metadata
- Authors
- Ahmed, A., Jorna, T., & Bhandari, S.
- Venue
- Nephron
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 133
- Issue
- 3
- Pages
- 147-158
- ISSN
- 1660-8151 (ISSN-L)
- 2235-3186
- OpenAlex
- W2475261460
- Cited by
- 11,717
- References
- 170
- FWCI
- 957.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.